Zhejiang Taimei Medical Technology Co., Ltd. (“TAIMEI TECH”) has resolved to introduce minor revisions to its existing Articles of Association as part of a broader effort to enhance corporate governance and align its internal regulations with operational and management needs.

The board of directors confirmed that the proposed amendments will be presented to shareholders for approval by special resolution at the company’s 2025 annual general meeting. In accordance with Hong Kong Listing Rules, TAIMEI TECH will distribute a circular detailing the amendments and the AGM notice to all shareholders in due course.

As of the announcement date, the board comprises six executive directors—Dr. Zhao Lu, Mr. Ma Dong, Mr. Zhang Hongwei, Mr. Lu Yiming, Mr. Huang Yufei and Ms. Ni Xiaomei—and three independent non-executive directors—Dr. Jiang Xiao, Dr. Li Zhiguo and Mr. Fung Che Wai Anthony.

The proposal underscores TAIMEI TECH’s ongoing commitment to strengthening governance structures and maintaining compliance with both domestic regulations and Hong Kong listing requirements.